<!DOCTYPE ui:UiBinder SYSTEM "http://dl.google.com/gwt/DTD/xhtml.ent">
<ui:UiBinder xmlns:ui="urn:ui:com.google.gwt.uibinder"
	xmlns:g="urn:import:com.google.gwt.user.client.ui"
	xmlns:w="urn:import:com.lmc.der.sixComposers.client.widgets"	
	xmlns:tbl_ama="urn:import:com.lmc.der.sixComposers.client.widgets.tables.ama"
	xmlns:tblfs="urn:import:com.lmc.der.sixComposers.client.widgets.tables.fstra"
	>
	<ui:style>
		
	</ui:style>
	<g:HTMLPanel width="155ex">
		<div style="font-weight:bold">
			Table 8: Summary of Test Concentrations in the Fish Short-Term Reproduction Assay with [test chemical].
		</div>
		<table>
		<col style="width:80%"/><col style="width:20%"/>
		<tr>
		<td>
			<tbl_ama:AMA2Table8/>
		</td>
		<td style="font-style:italic">
			Guideline Recommendations:
			EPA and OECD recommend that test item concentrations be
			maintained at a coefficient of variation (CV) &le;20%. 
		</td>
		</tr></table>
		<table>
		<tr>
			<td>
				<g:Button btnName='TBL8_ADD'>
					Add Test concentration					
				</g:Button>
			</td>
			<td>
				<g:Button btnName='TBL8_REM'>
					Remove Test concentration
				</g:Button>
			</td>
			<td>
				Abbreviations: 						
				<sup>CV</sup> Coefficient of variation.
			</td>						 
		</tr>
		</table>
		<table>
			<tr>
				<td>
					E. Observations
				</td>
			</tr>
			<tr>
				<td>
					Biological Endpoints:
				</td>
				<td>
					<w:DERRichTextAreaPUT name="FSTRA||MaterialsAndMethods>>Observations>>BiologicalEndpoints>>Html"  addStyleNames='bigRTA' ui:field='rtaBE'>
						<p style="color:firebrick">
								[List the parameters measured, including the specific clinical signs/sublethal effects that were considered.  Include the measurement interval for each observation (e.g., daily, day 7 and 21, day 21, other).]
						</p>
					</w:DERRichTextAreaPUT>
				</td>
			</tr>
			<tr>
				<td>
					Were raw (individual) data provided?  
				</td>
				<td>
					<w:DERListBoxYesNo name="FSTRA||MaterialsAndMethods>>Observations>>IndividualDataProvided" ui:field='lbRD'/>
				</td>
			</tr>
			<tr style="font-style:italic">
				<td colspan="2">
					EPA recommends that observations of survival, fecundity, fertilization success, secondary sex characteristics, and other clinical signs occur at least daily. 
					At test termination (day 21), additional observations include body weight and length, nuptial tubercle score, gonadal staging and histopathology, plasma vitellogenin, and plasma sex steroids (testosterone and 17&beta;-estradiol, if measured). 
					Gonado-somatic index (GSI) is calculated using a ratio of gonad weight to body weight (gonad weight to the nearest 0.1 mg / body weight in mg x 100) at test termination.
					<br/><br/>
					Clinical signs of overt toxicity may include (but are not limited to) hemorrhage, cessation of feeding, and other abnormal behavior.					
				</td>
			</tr>
		</table>
	</g:HTMLPanel>
</ui:UiBinder> 